Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Castleberry

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Pediatric Surgery|March 1, 1993
Thoracic neuroblastoma: a Pediatric Oncology Group studyG A Adams, S J Shochat, E I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group studyR P Castleberry, A B Cantor, A A Green, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1996
Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Neoplasia (New York, N.Y.)|June 23, 2001
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group studyP Mathew, M B Valentine, L C Bowman, et al.
Blood|December 1, 1987
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyA J Carroll, S C Raimondi, D L Williams, et al.
Cancer|July 27, 1999
The International Neuroblastoma Pathology Classification (the Shimada system)H Shimada, I M Ambros, L P Dehner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
American Journal of Obstetrics and Gynecology|August 24, 1999
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer groupB Cushing, R Giller, A Ablin, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2000
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group StudyC S Alvarado, W B London, A T Look, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Pediatric Surgery|March 1, 1993
Thoracic neuroblastoma: a Pediatric Oncology Group studyG A Adams, S J Shochat, E I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group studyR P Castleberry, A B Cantor, A A Green, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1996
Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Neoplasia (New York, N.Y.)|June 23, 2001
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group studyP Mathew, M B Valentine, L C Bowman, et al.
Blood|December 1, 1987
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyA J Carroll, S C Raimondi, D L Williams, et al.
Cancer|July 27, 1999
The International Neuroblastoma Pathology Classification (the Shimada system)H Shimada, I M Ambros, L P Dehner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
American Journal of Obstetrics and Gynecology|August 24, 1999
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer groupB Cushing, R Giller, A Ablin, et al.
Journal of Pediatric Hematology/Oncology|June 23, 2000
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group StudyC S Alvarado, W B London, A T Look, et al.
Pageof 8